SCHEMBL4852580

SCHEMBL4852580

CCC(C)O[P@@](=O)(O)C(CC(=O)c1ccc(OC)cc1)NC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ MAPT P10636 2/20 0.36
▸ LMNA P02545 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845956 0.90 L3MBTL1 (0.42) ALDH1A1MAPTLMNAMAPK1SMN1; SMN2
SCHEMBL4856863 0.90 L3MBTL1 (0.39) KMT2AMEN1MAPTLMNASMN1; SMN2
SCHEMBL4853494 0.89 L3MBTL1 (0.32) KMT2AMEN1LMNASMN1; SMN2HTT
SCHEMBL4855199 0.89 ALDH1A1 (0.35) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL5712076 0.89 KMT2A (0.38) KMT2AMEN1ALDH1A1TDP1SMN1; SMN2
SCHEMBL4853708 0.86 SLC6A4 (0.39) KMT2AMEN1ALDH1A1MAPTRAB9A
SCHEMBL4856627 0.82 MEN1 (0.30) KMT2AMEN1
SCHEMBL4852578 0.82 MAPT (0.42) KMT2AMEN1TAS1R3TAS1R1ALDH1A1
SCHEMBL4852576 0.82 MAPT (0.42) KMT2AMEN1TAS1R3TAS1R1ALDH1A1
SCHEMBL4857423 0.80 KMO (0.41) KMT2AMEN1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724275-B1 PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE JAPAN SCIENCE & TECH AGENCY (JP) 2015-04-08 — — EP disclosed
US-7375244-B2 Production method for aminophosphonic acid derivatives JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-05-20 — — US disclosed
US-20070142658-A1 Production method for aminophosphonic acid derivatives JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-06-21 — — US disclosed
EP-1724275-A1 PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE Japan Science and Technology Agency (JP) 2006-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142658-A1 Production method for aminophosphonic acid derivatives AASDHPPT, NPEPPS, DAO KMT2A 3395/4885MEN1 1745/4885TAS1R3 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback